Merrion appoints chief business officer
This article was originally published in Scrip
Executive Summary
Merrion Pharmaceuticals has appointed Dr Hing Kin Chan as chief business officer, responsible for the Irish drug delivery company's business development operations. Before joining Merrion, Dr Chan was chief business officer at DBV Technologies (France), vice-president of commercial development at ProBioGen (Germany) and business development director at Eurand, based in Milan (Italy).